Dishi Medical

Dishi Medical, also known as Dessight Biomedical, is a medical device manufacturer founded in Hangzhou, China, in 2021. The company specializes in developing surgical medical systems for ophthalmic conditions.

The core of its offering consists of microscopically assisted robots designed for retinal surgeries. These systems aim to overcome the physiological limitations of human hand movements, providing high precision, flexibility, and real-time operational response for ultra-high-level fundoplication procedures. The technology is also applicable to other microsurgery fields such as lymphatic, plastic, and neurosurgery, helping to reduce surgeon fatigue and enhance procedural accuracy.

The company operates on a B2B model, manufacturing and supplying these advanced robotic systems to healthcare institutions. Since its inception, Dishi Medical has progressed to a Series A stage, securing significant funding to advance its technology. The company has completed multiple funding rounds, including a Series A round in June 2025 that raised nearly 100 million CNY, led by investors such as Panlin Capital and Jinhe Capital. Its investor base also includes notable firms like Infinity Group, Fortune Capital, and Hillhouse Capital.

Keywords: ophthalmic surgical robots, retinal surgery, microsurgery systems, medical device manufacturer, fundoplication procedures, precision robotics, ophthalmic conditions, lymphatic surgery, neurosurgery applications, Panlin Capital, Infinity Group, Fortune Capital, Dessight Biomedical, Hangzhou, medical robotics